Oakland, CA, United States of America

Stuart Sweidler


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Stuart Sweidler and His Contributions to Enzyme Therapy

Introduction: Stuart Sweidler, an accomplished inventor based in Oakland, California, has made significant strides in the field of biotechnology. With one notable patent to his name, he has focused on developing innovative treatments and methods for diseases related to enzymatic deficiencies. His work is integral to advancing therapeutic solutions for patients suffering from specific genetic disorders.

Latest Patents: Stuart Sweidler holds a patent for the invention titled "Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme." This groundbreaking invention focuses on a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and its biologically active derivatives. The patent outlines various methods for treating diseases caused by deficiencies in this enzyme, including MPS VI, as well as methods for its production and purification, highlighting the potential for pharmaceutical formulations that can significantly impact patient care.

Career Highlights: Stuart Sweidler is associated with BioMarin Pharmaceutical Inc., a leading biotechnology company renowned for developing innovative biopharmaceuticals for serious diseases and medical conditions. His role in this organization underscores his commitment to enhancing therapeutic approaches through his inventive contributions.

Collaborations: Throughout his career, Sweidler has collaborated with talented professionals in the field, including colleagues Minmin Qin and Gary N Zecherle. Their collaborative efforts have contributed to advancing research and development in enzyme therapies, fostering innovation and progress within the biotechnology sector.

Conclusion: Stuart Sweidler exemplifies the spirit of innovation through his dedication to creating impactful solutions for enzymatic diseases. His patent for N-acetylgalactosamine-4-sulfatase not only showcases his inventiveness but also holds the promise of providing hope to patients affected by genetic disorders. As the biotechnology landscape continues to evolve, inventors like Stuart play a crucial role in shaping the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…